These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Bisphosphonates and cancer. More data using same database. Wright E; Seed PT; Schofield P; Jones R BMJ; 2010 Sep; 341():c5315. PubMed ID: 20880919 [No Abstract] [Full Text] [Related]
34. Jaw osteonecrosis related to bisphosphonates: a new concern for dentistry. Geist RY; Geist JR; Aksu M J Mich Dent Assoc; 2005 Nov; 87(11):40-2. PubMed ID: 16372547 [No Abstract] [Full Text] [Related]
35. Osteonecrosis of the jaw after treatment with bisphosphonates: is irreversible, so the focus must be on prevention. Landis BN; Richter M; Dojcinovic I; Hugentobler M BMJ; 2006 Nov; 333(7576):982-3. PubMed ID: 17095762 [No Abstract] [Full Text] [Related]
36. Bisphosphonates and spontaneous hip fractures: safety update for the clinical nurse specialist. O'Malley P Clin Nurse Spec; 2010; 24(4):194-5. PubMed ID: 20526119 [No Abstract] [Full Text] [Related]
38. Bisphosphonates and cancer. Two studies, same data source, two answers. de Vries F BMJ; 2010 Oct; 341():c5980. PubMed ID: 20978047 [No Abstract] [Full Text] [Related]
39. Bisphosphonates and bone...what have we learned? Guttenberg SA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):769-72. PubMed ID: 18835534 [No Abstract] [Full Text] [Related]
40. [Collaboration between doctor and dentist: the example of bisphosphonates]. Hurni V Rev Med Suisse; 2011 Jan; 7(279):198-9. PubMed ID: 21387711 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]